• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Phil Lands $10M to Expand End-to-End Prescription Delivery Service App

by Fred Pennic 08/16/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Phil Prescription Delivery Service

Phil, a San Francisco, CA-based end-to-end prescription management and delivery service connecting patients with local pharmacies has raised $10 million in funding led by Crosslink Capital. The round also includes participation from Eniac Ventures, Softtech VC, Forerunner Ventures, SV Angel, Silicon Valley Bank, and Transmedia Capital.

Founded in 2015, Phil connects users with community-based pharmacies to eliminate the frustration that can be associated with the prescription refill process through its website and mobile app. Phil acts as a concierge service that automates communication between doctors, insurers, pharmacy staff, and patients in order to ensure timely refill and efficient delivery of thousands of prescriptions across the country, directly to the patient’s door at no extra cost.

The company hopes to serve as an alternative to traditional pharmaceutical management aims to solve the problem of drug adherence, which drives between $100B and $300B in unnecessary medical costs in the U.S. each year. Phil’s key customer demographic is patients who take prescription medications on a regular basis; approximately one in five Americans take at least three a day. These individuals often contend with the uncertainty of running out of their medications, largely because current pharmacies fail them when it comes to coordinating between doctors and insurance agencies.

Phil works with dozens of partners and more than 8,000 doctors nationwide. As Phil’s customer prescription volume has doubled within Q1-Q2 and continues to accelerate, the startup plans to double internal staff by 2018 in order to continue providing top-quality customer service.

We believe care coordination between doctors, insurance and pharmacies is the biggest hurdle to patients receiving their meds on time, especially so for those who take medications regularly,” said Deepak Thomas, founder and CEO of Phil, who survived an eight-year run-in with chronic Lyme Disease in a statement. “With larger chain pharmacies, the consumer experience is often held captive by their business model that requires patients to return to the pharmacy, often multiple times a month. With Phil, we focus on providing a hands-off, concierge experience and rather than building our own pharmacy, we chose to partner with independently-owned pharmacies with strong community roots.”

 

Phil was recently certified by the National Association of Board of Pharmacies (NABP), which verifies online pharmacies and pharmacy-related websites globally, ensuring they are safe, legitimate and fully-licensed. Top-rated, independent pharmacies in all major states are now part of Phil’s fast-growing network, which since November 2016 has grown to cover 95 percent of the U.S. population.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Medication Adherence, Phil Inc., prescription adherence, Prescription Delivery

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |